文献速递炎症性肠病消化道肿瘤与早癌消化内镜

老年起病炎症性肠病中的结直肠癌:一项1969-2017年斯堪的纳维亚登记队列研究

Colorectal cancer in elderly-onset inflammatory bowel disease: a 1969-2017 Scandinavian register-based cohort study.
PubMed 文献 · Aliment Pharmacol Ther · 2022-08-02

该研究基于丹麦和瑞典国家患者登记及组织病理学数据,纳入1969-2017年确诊时年龄≥60岁的炎症性肠病患者,比较其与匹配的无炎症性肠病人群的结直肠癌诊断和死亡风险。结果显示,诊断后第一年结直肠癌发生率升高,但此后风险降低;2010年起,确诊一年后结直肠癌诊断的风险比低于 largely 未筛查的参考人群,支持内镜筛查和监测的获益。

要点

  • 老年起病炎症性肠病患者诊断后第一年结直肠癌发生率升高,此后风险降低。
  • 2010年起,确诊一年后结直肠癌诊断的风险比低于 largely 未筛查的参考人群。
  • 一旦诊断为结直肠癌,炎症性肠病患者与一般人群的结直肠癌死亡风险相似。

核心结论

  • 老年起病炎症性肠病中结直肠癌的超额风险可能源于偏倚,且在诊断后第一年之后未观察到。
  • 自2010年起,初始炎症性肠病诊断后超过一年的结直肠癌诊断风险比低于 largely 未筛查的参考人群,支持对炎症性肠病患者进行内镜筛查和监测的获益。

研究设计与样本

  • 基于丹麦和瑞典国家患者登记及组织病理学数据,识别1969-2017年间确诊时年龄≥60岁的炎症性肠病患者。
  • 将数据与癌症登记和死因登记链接,使用Cox回归估计结直肠癌诊断和死亡的风险比,并与按性别、年龄和地区匹配的无炎症性肠病个体进行比较。

主要发现

  • 7869例克罗恩病患者随访54220人年,21224例溃疡性结肠炎患者随访142635人年。
  • 克罗恩病患者中2.10%诊断为结直肠癌,参考个体为2.26%;溃疡性结肠炎患者中1.90%诊断为结直肠癌,参考个体为2.34%。
  • 中位随访时间分别为6年和7年。
  • 诊断后第一年结直肠癌发生率升高:克罗恩病为4.36(95% CI = 3.33-5.71),溃疡性结肠炎为2.48(95% CI = 2.03-3.02)。
  • 随访第一年后发生率降低:克罗恩病为0.69(95% CI = 0.56-0.86),溃疡性结肠炎为0.78(95% CI = 0.69-0.88)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous research indicates that the increased relative risk of colorectal cancer (CRC) in inflammatory bowel disease (IBD) is limited to young-onset IBD. AIM: To estimate risks of incident CRC and death from CRC in elderly-onset IBD METHODS: Patients diagnosed with IBD at age ≥ 60 years between 1969 and 2017 were identified using Danish and Swedish National Patient Registers and histopathology data. We linked data to Cancer and Causes of Death Registers and used Cox regression to estimate hazard ratios (HRs) for CRC diagnosis and death compared to matched (by sex, age, and region) IBD-free individuals. RESULTS: Among 7869 patients with Crohn's disease followed for 54,220 person-years, and 21,224 patients with ulcerative colitis (UC) followed for 142,635 person-years, 2.10% and 1.90% were diagnosed with CRC, compared to 2.26% and 2.34% of reference individuals (median follow-up 6 and 7 years). The incidence of CRC was elevated during the first year after IBD diagnosis: 4.36 (95% CI = 3.33-5.71) in Crohn's disease and 2.48 (95% CI = 2.03-3.02) in UC, but decreased after the first year of follow-up: 0.69 (95% CI = 0.56-0.86) and 0.78 (95% CI = 0.69-0.88). Once diagnosed with CRC, the risk of CRC death was similar for IBD patients and the general population. CONCLUSION: The excess risk of CRC in elderly-onset IBD was probably due to bias and not observed beyond the first year. From 2010, the HR for CRC diagnosis more than 1 year after initial IBD diagnosis was lower than in the largely unscreened reference population, supporting the benefit of endoscopic screening and surveillance in patients with IBD.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Everhov ÅH, Erichsen R, Järås J, et al. Colorectal cancer in elderly-onset inflammatory bowel disease: a 1969-2017 Scandinavian register-based cohort study. Aliment Pharmacol Ther. 2022. PMID: 35916190. doi:10.1111/apt.17175

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。